BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 15289858)

  • 61. Trifluridine/tipiracil overcomes the resistance of human gastric 5-fluorouracil-refractory cells with high thymidylate synthase expression.
    Matsuoka K; Nakagawa F; Kobunai T; Takechi T
    Oncotarget; 2018 Mar; 9(17):13438-13450. PubMed ID: 29568368
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.
    de Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; Reichelt W; Beigi M; Clausen OP; Galteland E; Stokke T
    Int J Oncol; 2004 May; 24(5):1279-88. PubMed ID: 15067352
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
    Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL
    Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chemo-radio-gene therapy for colorectal cancer cells using Escherichia coli uracil phosphoribosyltransferase gene.
    Koyama F; Fujii H; Mukogawa T; Ueno M; Hamada H; Ishikawa H; Doi S; Nakao T; Matsumoto H; Shimatani H; Takeuchi T; Nakajima Y
    Anticancer Res; 2003; 23(2B):1343-8. PubMed ID: 12820392
    [TBL] [Abstract][Full Text] [Related]  

  • 66. 5-fluoro-2'-deoxyuridine-induced cdc25A accumulation correlates with premature mitotic entry and clonogenic death in human colon cancer cells.
    Parsels LA; Parsels JD; Tai DC; Coughlin DJ; Maybaum J
    Cancer Res; 2004 Sep; 64(18):6588-94. PubMed ID: 15374972
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
    Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combined effect of 5-fluorouracil and carboplatin against human gastric cancer cell lines in vitro and in vivo.
    Saikawa Y; Kubota T; Kuo TH; Tanino H; Kase S; Furukawa T; Watanabe M; Ishibiki K; Kitajima M; Hoffman RM
    Anticancer Res; 1994; 14(2A):461-4. PubMed ID: 8017848
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Determinants of trifluorothymidine sensitivity and metabolism in colon and lung cancer cells.
    Temmink OH; de Bruin M; Comijn EM; Fukushima M; Peters GJ
    Anticancer Drugs; 2005 Mar; 16(3):285-92. PubMed ID: 15711180
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 5-Fluorouracil incorporated into DNA is excised by the Smug1 DNA glycosylase to reduce drug cytotoxicity.
    An Q; Robins P; Lindahl T; Barnes DE
    Cancer Res; 2007 Feb; 67(3):940-5. PubMed ID: 17283124
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
    Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
    Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Studies on the mechanism of antitumor activity of 5-FU and its derivatives--relationship between the inhibition of tumor growth and the inhibition of thymidylate synthetase in vivo].
    Nakamura H; Yu-Qin W; Miyauchi S; Nishioka N; Tanaka H; Harada N; Shirasaka T; Fujii S
    Gan To Kagaku Ryoho; 1984 May; 11(5):1049-55. PubMed ID: 6426401
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytotoxic effects and mechanisms of an alteration in the dose and duration of 5-fluorouracil.
    Patel M; Ardalan K; Hochman I; Tian EM; Ardalan B
    Anticancer Res; 2003; 23(1A):447-52. PubMed ID: 12680247
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Defective facilitated diffusion of nucleosides, a primary mechanism of resistance to 5-fluoro-2'-deoxyuridine in the HCT-8 human carcinoma line.
    Sobrero AF; Moir RD; Bertino JR; Handschumacher RE
    Cancer Res; 1985 Jul; 45(7):3155-60. PubMed ID: 3159474
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
    You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synergistic antitumor effects of fleroxacin with 5-fluorouracil in vitro and in vivo for bladder cancer cell lines.
    Nishikawa T; Kohjimoto Y; Nishihata M; Ebisuno S; Hara I
    Urology; 2009 Dec; 74(6):1370-6. PubMed ID: 19428092
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, with irinotecan hydrochloride on human colorectal and gastric cancer xenografts.
    Nukatsuka M; Nakagawa F; Saito H; Sakata M; Uchida J; Takechi T
    Anticancer Res; 2015 Mar; 35(3):1437-45. PubMed ID: 25750295
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Resistance of colorectal cancer cells to 5-FUdR and 5-FU caused by Mycoplasma infection.
    Jetté L; Bissoon-Haqqani S; Le François B; Maroun JA; Birnboim HC
    Anticancer Res; 2008; 28(4B):2175-80. PubMed ID: 18751392
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray.
    Park JS; Young Yoon S; Kim JM; Yeom YI; Kim YS; Kim NS
    Cancer Lett; 2004 Oct; 214(1):19-33. PubMed ID: 15331170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.